Saturday, February 27, 2021

China arrests at least 80 in fake Covid-19 vaccine ring

The 'vaccines' were sold in China and to other unidentified countries,

Other News

Suami isteri pengusaha van tak sabar tunggu sekolah dibuka

Berita mengenai pembukaan semula sesi persekolahan pada 1 Mac depan bagaikan “cahaya di hujung terowong” kepada pasangan pengusaha van sekolah yang memutuskan untuk pulang...

Husband-wife van drivers can’t wait for schools to open again

Ismail Raja Mat and his wife Norhayati Muda have bills piling up and children who need to be fed.

AmBank to pay RM2.83 billion settlement over 1MDB scandal

This is in addition to the RM53.7 million penalty imposed by Bank Negara Malaysia and paid by AmBank Group.

AmBank bayar Putrajaya RM2.83 bilion disebabkan penglibatan dalam skandal 1MDB

Pembayaran ini akan menguntungkan rakyat Malaysia kata Menteri Kewangan Tengku Zafrul Aziz.

Palm oil churns trouble in Canadian ‘hard butter’ puzzle

The pandemic has increased demand for butter, so farmers are feeding extra palm oil derivatives to their cows to produce more milk fat.

Chinese police have arrested more than 80 suspected members of a criminal gang manufacturing and selling fake Covid-19 vaccines, including exporting to other countries, the official Xinhua News Agency has reported.

Police in Beijing and in Jiangsu and Shandong provinces broke up the group that was producing the fake vaccines, which consisted of a simple saline solution,

The “vaccines” were sold in China and to other countries, although it was unclear which countries were the recipients.

“China has already reported the situation to the relevant countries,” foreign ministry spokesman Wang Wenbin told reporters.

“The Chinese government highly values vaccine safety and will continue to take efforts to strictly prosecute any counterfeits,” Wang said. “China will also strengthen our law enforcement cooperation with the relevant countries.”

China has a long history of vaccine scandals. In 2016, police arrested the leaders of a ring that sold millions of improperly stored vaccines across the country.

In response to recent scandals, China reformed vaccine safety regulations and increased criminal penalties for those caught making counterfeits, reports the Associated Press.

In the past, many Chinese citizens did not trust homegrown vaccines, but since the pandemic struck, confidence has been higher.

In a recent survey published by Chinese business magazine Caixin, 74% of respondents said they would take a Covid-19 vaccine if it was available.

China has at least seven Covid-19 vaccines in the last stages of clinical trials, and has one made by state-owned Sinopharm, that has been approved for domestic use.

Chinese vaccine makers have seized the opportunity provided by the pandemic to go global, with Sinopharm and other Chinese companies selling or donating their vaccines to at least 27 countries around the world including Brazil, Turkey and Indonesia.

Domestically, China has administered more than 24 million doses of its homegrown vaccine candidates, as part of a mass vaccination campaign.

China has so far refrained from giving the vaccine to the most elderly, instead targeting key groups such as health professionals and workers in food-related industries, as well as adults up to the age of 59.

Follow us on Telegram for the latest updates:

Subscribe to our newsletter

To be updated with all the latest news and analyses.

Related Articles

Daily cases back over 2,000, death toll up by 11

2,253 new cases, 3,085 recoveries.

Maximum RM10,000 fine for SOP offenders beginning March 11

Companies or corporations that violate the SOPs can be fined up to RM50,000.

China approves 2 more home-grown Covid-19 vaccines for use

China is exporting vaccines to 27 countries and providing free doses to 53 others, a foreign ministry spokesman says.

US approves Pfizer vaccine storage at normal freezer temperature

The move loosens a previous requirement that the vaccine should be stored at ultra-low temperatures, between -80 to -60 degrees Celsius.

It’s not just about patent rights, expert says on ways to make Covid jabs cheaper

India's Serum Institute offers a good example of overcoming the problem of vaccine exclusivity during the current health emergency.